HEADER PROTEIN BINDING 02-JUL-01 1JIE TITLE CRYSTAL STRUCTURE OF BLEOMYCIN-BINDING PROTEIN FROM BLEOMYCIN- TITLE 2 PRODUCING STREPTOMYCES VERTICILLUS COMPLEXED WITH METAL-FREE TITLE 3 BLEOMYCIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: BLEOMYCIN-BINDING PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES VERTICILLUS; SOURCE 3 ORGANISM_TAXID: 29309; SOURCE 4 GENE: BLMA; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: HB101; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PKKTRP KEYWDS PROTEIN-LIGAND COMPLEX, PROTEIN BINDING EXPDTA X-RAY DIFFRACTION AUTHOR M.SUGIYAMA,T.KUMAGAI,M.HAYASHIDA,M.MARUYAMA,Y.MATOBA REVDAT 5 25-OCT-23 1JIE 1 REMARK REVDAT 4 04-OCT-17 1JIE 1 REMARK REVDAT 3 24-FEB-09 1JIE 1 VERSN REVDAT 2 18-DEC-02 1JIE 1 REMARK REVDAT 1 06-FEB-02 1JIE 0 JRNL AUTH M.SUGIYAMA,T.KUMAGAI,M.HAYASHIDA,M.MARUYAMA,Y.MATOBA JRNL TITL THE 1.6-A CRYSTAL STRUCTURE OF THE COPPER(II)-BOUND JRNL TITL 2 BLEOMYCIN COMPLEXED WITH THE BLEOMYCIN-BINDING PROTEIN FROM JRNL TITL 3 BLEOMYCIN-PRODUCING STREPTOMYCES VERTICILLUS. JRNL REF J.BIOL.CHEM. V. 277 2311 2002 JRNL REFN ISSN 0021-9258 JRNL PMID 11706014 JRNL DOI 10.1074/JBC.M103278200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH Y.KAWANO,T.KUMAGAI,K.MUTA,Y.MATOBA,J.DAVIES,M.SUGIYAMA REMARK 1 TITL THE 1.5 A CRYSTAL STRUCTURE OF A BLEOMYCIN RESISTANCE REMARK 1 TITL 2 DETERMINANT FROM BLEOMYCIN-PRODUCING STREPTOMYCES REMARK 1 TITL 3 VERTICILLUS REMARK 1 REF J.MOL.BIOL. V. 295 915 2000 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.1999.3404 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.MARUYAMA,T.KUMAGAI,Y.MATOBA,M.HAYASHIDA,T.FUJII,Y.HATA, REMARK 1 AUTH 2 M.SUGIYAMA REMARK 1 TITL CRYSTAL STRUCTURES OF THE TRANSPOSON TN5-CARRIED BLEOMYCIN REMARK 1 TITL 2 RESISTANCE DETERMINANT UNCOMPLEXED AND COMPLEXED WITH REMARK 1 TITL 3 BLEOMYCIN REMARK 1 REF J.BIOL.CHEM. V. 276 9992 2001 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.M009874200 REMARK 1 REFERENCE 3 REMARK 1 AUTH T.KUMAGAI,K.MUTA,Y.MATOBA,Y.KAWANO,N.KAMIYA,J.DAVIES, REMARK 1 AUTH 2 M.SUGIYAMA REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY DIFFRACTION STUDIES OF REMARK 1 TITL 2 BLEOMYCIN-BINDING PROTEIN FROM BLEOMYCIN-PRODUCING REMARK 1 TITL 3 STREPTOMYCES VERTICILLUS REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 54 127 1998 REMARK 1 REFN ISSN 0907-4449 REMARK 1 DOI 10.1107/S0907444997008871 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 75.9 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.156 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.160 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 10.900 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1862 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 17018 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.143 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.148 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 11.100 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1592 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 14369 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1868 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 192 REMARK 3 SOLVENT ATOMS : 139 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2199.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 5 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 8949 REMARK 3 NUMBER OF RESTRAINTS : 8738 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 ANGLE DISTANCES (A) : 0.030 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.022 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.050 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.060 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.010 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.040 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1JIE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 16-JUL-01. REMARK 100 THE DEPOSITION ID IS D_1000013806. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-OCT-99 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : R-AXIS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19023 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 80.3 REMARK 200 DATA REDUNDANCY : 3.480 REMARK 200 R MERGE (I) : 0.06900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 55.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.16900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.250 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: PDB ENTRY 1QTO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG4000, AMMONIUM ACETATE, SODIUM REMARK 280 CACODYLATE, PH 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.71000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A HOMODIMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -46.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE A 33 CB - CG - CD1 ANGL. DEV. = 5.1 DEGREES REMARK 500 ARG A 42 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 ARG A 47 NE - CZ - NH1 ANGL. DEV. = 4.1 DEGREES REMARK 500 ARG A 109 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 ASP B 270 CB - CG - OD1 ANGL. DEV. = 5.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 35 -144.95 -142.88 REMARK 500 ASP A 70 87.11 -152.13 REMARK 500 ASP B 235 -146.13 -130.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BLM B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BLM A 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1QTO RELATED DB: PDB REMARK 900 1QTO CONTAINS THE SAME PROTEIN UNCOMPLEXED WITH BLEOMYCIN REMARK 900 RELATED ID: 1ECS RELATED DB: PDB REMARK 900 1ECS CONTAINS THE SIMILAR PROTEIN(BLEOMYCIN RESISTANCE PROTEIN) REMARK 900 UNCOMPLEXED WITH BLEOMYCIN REMARK 900 RELATED ID: 1EWJ RELATED DB: PDB REMARK 900 1EWJ CONTAINS THE SIMILAR PROTEIN(BLEOMYCIN RESISTANCE DETERMINANT) REMARK 900 COMPLEXED WITH METAL-FREE BLEOMYCIN REMARK 900 RELATED ID: 1JIF RELATED DB: PDB REMARK 900 1JIF CONTAINS THE SAME PROTEIN COMPLEXED WITH COPPER(II)-BLEOMYCIN DBREF 1JIE A 1 122 UNP Q53793 Q53793_9ACTO 1 122 DBREF 1JIE B 201 322 UNP Q53793 Q53793_9ACTO 1 122 SEQRES 1 A 122 MET VAL LYS PHE LEU GLY ALA VAL PRO VAL LEU THR ALA SEQRES 2 A 122 VAL ASP VAL PRO ALA ASN VAL SER PHE TRP VAL ASP THR SEQRES 3 A 122 LEU GLY PHE GLU LYS ASP PHE GLY ASP ARG ASP PHE ALA SEQRES 4 A 122 GLY VAL ARG ARG GLY ASP ILE ARG LEU HIS ILE SER ARG SEQRES 5 A 122 THR GLU HIS GLN ILE VAL ALA ASP ASN THR SER ALA TRP SEQRES 6 A 122 ILE GLU VAL THR ASP PRO ASP ALA LEU HIS GLU GLU TRP SEQRES 7 A 122 ALA ARG ALA VAL SER THR ASP TYR ALA ASP THR SER GLY SEQRES 8 A 122 PRO ALA MET THR PRO VAL GLY GLU SER PRO ALA GLY ARG SEQRES 9 A 122 GLU PHE ALA VAL ARG ASP PRO ALA GLY ASN CYS VAL HIS SEQRES 10 A 122 PHE THR ALA GLY GLU SEQRES 1 B 122 MET VAL LYS PHE LEU GLY ALA VAL PRO VAL LEU THR ALA SEQRES 2 B 122 VAL ASP VAL PRO ALA ASN VAL SER PHE TRP VAL ASP THR SEQRES 3 B 122 LEU GLY PHE GLU LYS ASP PHE GLY ASP ARG ASP PHE ALA SEQRES 4 B 122 GLY VAL ARG ARG GLY ASP ILE ARG LEU HIS ILE SER ARG SEQRES 5 B 122 THR GLU HIS GLN ILE VAL ALA ASP ASN THR SER ALA TRP SEQRES 6 B 122 ILE GLU VAL THR ASP PRO ASP ALA LEU HIS GLU GLU TRP SEQRES 7 B 122 ALA ARG ALA VAL SER THR ASP TYR ALA ASP THR SER GLY SEQRES 8 B 122 PRO ALA MET THR PRO VAL GLY GLU SER PRO ALA GLY ARG SEQRES 9 B 122 GLU PHE ALA VAL ARG ASP PRO ALA GLY ASN CYS VAL HIS SEQRES 10 B 122 PHE THR ALA GLY GLU HET BLM A 402 96 HET BLM B 401 96 HETNAM BLM BLEOMYCIN A2 HETSYN BLM N1-[3-(DIMETHYLSULFONIO)-PROPYL]BLEOMYCINAMIDE FORMUL 3 BLM 2(C55 H85 N17 O21 S3) FORMUL 5 HOH *139(H2 O) HELIX 1 1 ASP A 15 THR A 26 1 12 HELIX 2 2 HIS A 55 ASP A 60 1 6 HELIX 3 3 ASP A 70 ARG A 80 1 11 HELIX 4 4 ASP B 215 THR B 226 1 12 HELIX 5 5 HIS B 255 ASP B 260 1 6 HELIX 6 6 ASP B 270 ALA B 279 1 10 SHEET 1 A 8 GLU A 30 GLY A 34 0 SHEET 2 A 8 PHE A 38 ARG A 43 -1 O GLY A 40 N ASP A 32 SHEET 3 A 8 ILE A 46 ARG A 52 -1 O ILE A 46 N ARG A 43 SHEET 4 A 8 PHE A 4 ALA A 13 1 O PRO A 9 N HIS A 49 SHEET 5 A 8 SER B 263 VAL B 268 -1 O SER B 263 N VAL A 10 SHEET 6 A 8 CYS B 315 ALA B 320 1 O CYS B 315 N ALA B 264 SHEET 7 A 8 GLU B 305 ARG B 309 -1 O PHE B 306 N PHE B 318 SHEET 8 A 8 ALA B 293 MET B 294 -1 O ALA B 293 N ARG B 309 SHEET 1 B 8 GLU B 230 GLY B 234 0 SHEET 2 B 8 PHE B 238 ARG B 243 -1 O GLY B 240 N ASP B 232 SHEET 3 B 8 ILE B 246 ARG B 252 -1 O ILE B 246 N ARG B 243 SHEET 4 B 8 PHE B 204 ALA B 213 1 O PRO B 209 N HIS B 249 SHEET 5 B 8 SER A 63 VAL A 68 -1 O SER A 63 N VAL B 210 SHEET 6 B 8 CYS A 115 ALA A 120 1 O CYS A 115 N ALA A 64 SHEET 7 B 8 GLY A 103 ARG A 109 -1 O ARG A 104 N ALA A 120 SHEET 8 B 8 ALA A 93 MET A 94 -1 O ALA A 93 N ARG A 109 SHEET 1 C 8 GLU B 230 GLY B 234 0 SHEET 2 C 8 PHE B 238 ARG B 243 -1 O GLY B 240 N ASP B 232 SHEET 3 C 8 ILE B 246 ARG B 252 -1 O ILE B 246 N ARG B 243 SHEET 4 C 8 PHE B 204 ALA B 213 1 O PRO B 209 N HIS B 249 SHEET 5 C 8 SER A 63 VAL A 68 -1 O SER A 63 N VAL B 210 SHEET 6 C 8 CYS A 115 ALA A 120 1 O CYS A 115 N ALA A 64 SHEET 7 C 8 GLY A 103 ARG A 109 -1 O ARG A 104 N ALA A 120 SHEET 8 C 8 GLY A 98 SER A 100 -1 N GLY A 98 O GLU A 105 SITE 1 AC1 31 LYS A 3 ASP A 32 PHE A 33 PHE A 38 SITE 2 AC1 31 ARG A 47 SER A 51 ARG A 52 ARG A 104 SITE 3 AC1 31 ALA B 259 ASP B 260 ASN B 261 THR B 262 SITE 4 AC1 31 TRP B 265 TYR B 286 ALA B 302 ARG B 309 SITE 5 AC1 31 GLY B 313 CYS B 315 GLU B 322 HOH B 520 SITE 6 AC1 31 HOH B 522 HOH B 533 HOH B 555 HOH B 569 SITE 7 AC1 31 HOH B 571 HOH B 575 HOH B 580 HOH B 592 SITE 8 AC1 31 HOH B 595 HOH B 609 HOH B 628 SITE 1 AC2 33 ALA A 59 ASP A 60 ASN A 61 THR A 62 SITE 2 AC2 33 TRP A 65 TYR A 86 THR A 89 PRO A 101 SITE 3 AC2 33 ALA A 102 ARG A 109 GLY A 113 CYS A 115 SITE 4 AC2 33 HIS A 117 GLU A 122 HOH A 511 HOH A 512 SITE 5 AC2 33 HOH A 513 HOH A 530 HOH A 550 HOH A 556 SITE 6 AC2 33 HOH A 559 HOH A 585 HOH A 603 HOH A 605 SITE 7 AC2 33 HOH A 620 HOH A 621 PHE B 233 PHE B 238 SITE 8 AC2 33 ARG B 247 SER B 251 ARG B 252 GLU B 299 SITE 9 AC2 33 ARG B 304 CRYST1 35.520 83.420 43.240 90.00 104.88 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.028153 0.000000 0.007480 0.00000 SCALE2 0.000000 0.011988 0.000000 0.00000 SCALE3 0.000000 0.000000 0.023929 0.00000